Funding for this research was provided by:
Brain and Behavior Research Foundation (27068)
National Institute of Mental Health (U01 MH081857, U01 MH066134, U01 MH081988, U01 MH081944, U01 MH081902, P50 MH066286, U01 MH82022, R01 MH076989, R01 U01 MH066069, U01 MH081928)
Received: 4 May 2018
Accepted: 30 August 2018
First Online: 21 September 2018
: T.D.C. has served as a consultant for Boehringer–Ingelheim Pharmaceuticals and Lundbeck A/S. The remaining authors declare no competing interests.